ACH
TBIO

ArrowMark Colorado Holdings’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

ArrowMark Colorado Holdings’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-15,000
Closed -$113K – 349
2018
Q4 		$113K Sell
15,000
-352,744
-96% -$2.58M ﹤0.01% 331
2018
Q3 		$3.68M Sell
367,744
-321,950
-47% -$3.75M 0.03% 253
2018
Q2 		$8.72M Buy
+689,694
New +$8.33M 0.08% 202

Other funds holding TBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
AVA
Atlas Venture Advisors Boston, Massachusetts $143M AUM 25.68% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

ArrowMark Colorado Holdings's TBIO Position: Q1 2019 in Review

ArrowMark Colorado Holdings sold out of Translate Bio, Inc. Common Stock (TBIO) in Q1 2019, closing a stake of 15,000 shares — an estimated $113K sold.

ArrowMark Colorado Holdings first reported a position in TBIO in Q2 2018 and held it in 3 quarters. The position peaked at $8.72M in Q2 2018. 52 funds tracked by Wall St. Rank hold TBIO as of Q1 2019.

  • ArrowMark Colorado Holdings reported no remaining Translate Bio, Inc. Common Stock position as of Q1 2019 after selling out during the quarter.
  • ArrowMark Colorado Holdings sold 15,000 Translate Bio, Inc. Common Stock shares in Q1 2019, an estimated $113K.
  • ArrowMark Colorado Holdings first reported a position in Translate Bio, Inc. Common Stock in Q2 2018 and held it in 3 quarters.
  • ArrowMark Colorado Holdings's Translate Bio, Inc. Common Stock position peaked at $8.72M in Q2 2018.
  • 52 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q1 2019.

Based on ArrowMark Colorado Holdings's 13F filing for Q1 2019, filed 15 May 2019.